期刊文献+

儿童血友病病人临床资料及现状分析 被引量:44

Evaluation Clinical data and Current Condition of Children Hemophilic Patients in China
下载PDF
导出
摘要 目的通过对儿童血友病病人临床资料的总结,分析中国儿童血友病病人现状,为开展进一步诊治、综合关怀工作提供依据。方法总结分析首都医科大学附属北京儿童医院血液病中心血友病工作组自2003年1月到2007年5月4年余收集的145份病例资料:结果(1)一般情况:病人来自19个省市自治区,年龄6月~18岁,中位年龄6.9岁,各年龄组均占1/4,血友病A:B=5.17:1,中度占43.4%,无家族病史占65.5%。(2)临床情况:①首次出血:出生当天~14岁,中位年龄12月。轻、中度常有诱因:多为医源性穿刺、外伤,年龄多〉1岁;重度以无诱因自发皮肤黏膜出血、〈1岁多见。②关市出血58.6%,其中87%已存在靶关节/慢性血友病性滑膜炎:中度、轻度分别为54.8%、21.2%,疾病程度重,病程长,发生率增加。③颅内出血13.1%:其中15.8%死亡和/或放弃,26.3%遗留癫痫后遗症,10.6%接受手术。总死亡率2.76%。(3)治疗情况:①急性出血时应用因子替代36.8%,因子供应不充足45.3%,出血时没有替代治疗17.9%。②没有常规监测并发症。(4)牛活质量:①心理评估:自身评价不满占47.8%,情感不满占95.6%。②参与社会活动、自理能力:6~12岁25.2%处于基本失学状态,12~18岁为50%。在校/幼儿园66.7%不参与活动。日常生活72.7%不能完成。③70.3%家庭疾病负担明显严重,与疾病程度和年龄无关。结论中国血友病儿童(1)发病情况同其他报道,无家族史者多。(2)首次出血各年龄组均有发生,需注意外伤后非正常及自发出血,及早诊断避免延误。(3)整体致残率离:严重关节并变多;硕内出血没有得到及时治疗,半数以上存在严重并发症。(4)生活质量差:多数孩子为避免出血而选择不活动,被迫选择回避/不参与社会活动及社会交流,心理发育严重受到影响。无论年龄和疾病程度,疾病均造成严重家庭负担。现状急需改变。 Objective To describe clinical data of children hemophilic patients from China seen at our hospital and to describe their clinical conditions with an aim to provide the basic data for further studies and for the development hemophilia comprehensive care in China. Methods We retrospectively analyzed our patients 145 cases seen between 2003-2007. Results ( 1 ) There were 147 patients came from 19 provinces of China (the majority from northeastern China) with a median age of 6.9 year (range 6m to 18y). Majority are hemophilia A (A: B = 5.17:1 ) with 29.7% severe disease and 43.4% moderate. Family history was negative in 65.5%. (2)Clinical information:①First bleed episode overall at median age of 12 months (range 1 d to 14y). Majority of the first bleeding episodes occurred after 1 year age in mild/moderate patients with procedures and trauma as the precipitation causes. Patients with severe disease had spontaneous bleeding with the majority having the first bleed episode before 1 year age. ② Joint bleeds occurred in 58.6% of all patients (including 54.8% moderate patients and 21.2% mild patients) with 87% of whom having severe joint damage. ③ ICH occurs in 13.1% patients with a mortality rate of 15.8% , CNS sequelae in 26.3%. Operative intervention was performed in 10.6%. Severe bleed episodes also occurred, among them 60% of patients were moderate. The overall mortality was 2.76%. (3) Treatment of bleed episode: 36.8% received concen-trates, 45.3% received fresh frozen plasma/cryoprecipitate or suboptimal doses of concentrate, and 17.9% received no replacement therapy. Complications of replacement therapy : occurred rarely, but could be related to the lack of monitoring. (4) Quality of life : ① Psychologic development : was self rated as unsatisfactory in 47.8% and emotionally rated unsatisfactory in 95.6%. ② Activities and self-care: poor to no attendance in about 25.2% of those in 6-12 years age group, and 50% in the 12 to 18 years age group. About 66.7% who attends school did take part in physical activity. About 72.7% of patients were unable to care for themselves.③ About 70.3 % family reported significant family disease burden with little relationship to patient age or disease severities. Conclusions (1) The general condition of hemophilia children in China was the same with that of other reports, but with a higher prevalence of negative family history. (2) First bleed episode could occur in every age, and in order to avoid severe bleeding, we must pay attention to bleed episode occurred after trauma or spontaneously. ( 3 ) There is a high prevalence of severe bleed related disability at young age, occurring mainly in patients with moderate disease, ICH was complicated by a high frequency of neurological sequelae owing to delayed or insufficient treatment. Indicate the likely causes, such as problems with early diagnosis, education and training, with the urgent and proper treatment and prevention, etc. (4) Poor quality of life : because of worries about bleeding, majority of the children chose not to participate in physical and social activities/interactions, which adversely affecting their psychology development. Disease burden to the families was significant irrespective of patient' s age or disease severities. Improvement in the care of hemophilia children is urgently needed.
出处 《血栓与止血学》 2008年第3期116-120,共5页 Chinese Journal of Thrombosis and Hemostasis
关键词 血友病 儿童 Hemophilia Children
  • 相关文献

参考文献12

  • 1[1]KASPER CK.Concentrate safety and efficacy[J].Hemophilia,2002,8:161-165.
  • 2[2]EVATT B.L.,BLACK C,BATOROVA A,et al.Comprehensive care for hemophilia around the world[J].Haemophilia,2004,10,(Suppl.4):9-13.
  • 3[3]CARCAO MD,ALEDORT LM.Prophylaxis in the hemophilia population-optimizing therapy[J].Haemophilia,2007,13:227 232.
  • 4[4]MANCO-JOHNSON MJ,PETTERSSON H,PETRINI P,et al.Physical therapy and imaging outcome measures in a hemophilia population treated with factor prophylaxis:current status and future directions[J].Hemophilia,2004,10 (Suppl.4):88-93.
  • 5[5]HIGH KA.Gene therapy:a 2001 perspective[J].Haemophilia,2001,7(Suppl.1):23-27.
  • 6[6]KAR A,MIRKAZEMI R,SINGH P,et al.Disability in Indian patients with hemophilia[J].Haemophilia,2007,1-7.
  • 7[7]CHUANSUMRIT A.Treatment of haemophilia in the developing countries[J].Haemophilia,2003,9:387-390.
  • 8[8]SU Y,WONG WY,LAIL A,et al.Long-term major joint outcomes in young adults with hemophilia:interim data from the HGDS[J].Hemophilia,2007,1-4.
  • 9[9]MULDER K,LLINAS A.The target joint[J].Hemophilia,2004,10(Suppl 4):152-156.
  • 10朱江,贺民,游潮.神经外科血友病患者的处理[J].华西医学,2005,20(4):771-772. 被引量:3

二级参考文献22

  • 1Christopher Haslett,Edwin R.Chilvers,John A.A.Hunter,et al.DAVISION'S Principles and Practice of MEDICINE.18th Edition.Singapore: Churchill Livingstone,2000: 789-793.
  • 2Hoyer LW,Hemophilia A.N Engl J Med,1994; 330: 38-47.
  • 3John P Greer,John Foerster,John N Lukens,et al.Wintrobe's clinical hema ss clinicth edition.Philadelphia: LIPPINCOTT WILLIAMS&WILKINS,2004: 1620-1625.
  • 4A Victor Hoffbrand,John E Pettit.Color Atlas of Clinical Hematology[M].3rd edition.London: Harcourt Publishers Limited,2000.
  • 5Roberts HR,Hoffman M.Haemophilia A and Haemophilia B.In: Beutler E,Lichtman MA,Coller BS,et al.Williams hematology[M].6th ed,edited.New York: McGraw-Hill Companies,2001:1639-1657.
  • 6Summary Report.Delivery of treatment for haemophilia[M].Haemophilia,2003,9:403-404.
  • 7Tagariello G,Davoli PG,Gajo GB,et al.Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion[J].Haemophilia,1999,5:426-430.
  • 8Renom P,Wibaut B,Rigot JM,et al.Desmopressin is not always effective in mild haemophilia A patients undergoing urological surgery: the need of standardized protocols[J].Haemophilia,2002,8:711-714.
  • 9Rodeghiero F,Castaman G,Bona ED,et al.Consistency of responses to repeapted DDAVP infusions in patients with von Willebrand's disease and haemophilia A[J].Blood,1989,74:1997-2000.
  • 10Campbell P J,Rickard K A.Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience[J].Aust N Z J Med.1998,28(4):440-445.

共引文献2

同被引文献335

引证文献44

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部